A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes
Sponsor
Hoffmann-La Roche (Industry)
Overall Status
Completed
CT.gov ID
NCT00002377
Collaborator
(none)
19
71
Study Details
Study Description
Brief Summary
To investigate the efficacy and safety of RS-79070 when used as induction therapy in patients with newly diagnosed peripheral retinitis. To assess the effects of induction and maintenance level dosing of RS-79070 on CMV viral load, estimated by plasma CMV PCR. To assess the pharmacokinetics of ganciclovir following administration of RS-79070 in the target population.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
Phase 3 |
Study Design
Study Type:
Interventional
Intervention Model:
Parallel Assignment
Primary Purpose:
Treatment
Actual Study Start Date
:
Jan 1, 1997
Actual Primary Completion Date
:
Dec 1, 2002
Actual Study Completion Date
:
Dec 1, 2002
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
14 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Documented AIDS diagnosis
-
Newly diagnosed peripheral CMV retinitis
-
More than 3 weeks of previous therapy for CMV retinitis
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Univ of California / Irvine | Irvine | California | United States | 92697 |
2 | Univ of California / San Diego / Dept of Pediatrics | La Jolla | California | United States | 92093 |
3 | Univ of California / San Diego Treatment Ctr | San Diego | California | United States | 92103 |
4 | Davies Med Ctr / Institute for HIV Research | San Francisco | California | United States | 94114 |
5 | Kaiser Permanente Med Ctr | San Francisco | California | United States | 94115 |
6 | QUEST Clinical Research | San Francisco | California | United States | 94115 |
7 | Dr Alan Palestine | Washington, D.C. | District of Columbia | United States | 20006 |
8 | Univ of Miami School of Medicine | Miami | Florida | United States | 33136 |
9 | Emory Eye Clinic | Atlanta | Georgia | United States | 30322 |
10 | New England Med Ctr | Boston | Massachusetts | United States | 02111 |
11 | New York Univ Med Ctr | New York | New York | United States | 10016 |
12 | St Luke's - Roosevelt Hosp Ctr / Div of Infect Dis | New York | New York | United States | 10019 |
13 | New York Hosp - Cornell Med Ctr | New York | New York | United States | 10021 |
14 | Duke Univ Eye Ctr | Durham | North Carolina | United States | 27710 |
15 | Austin Infectious Disease Consultants | Austin | Texas | United States | 78705 |
16 | St Pauls Hosp | Vancouver | British Columbia | Canada | |
17 | The Toronto Hosp / Dept of Infectious Disease | Toronto | Ontario | Canada | |
18 | Montreal Chest Institute | Montreal | Quebec | Canada | |
19 | Royal Victoria Hosp | Montreal | Quebec | Canada |
Sponsors and Collaborators
- Hoffmann-La Roche
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Hoffmann-La Roche
ClinicalTrials.gov Identifier:
NCT00002377
Other Study ID Numbers:
- WV15376
First Posted:
Aug 31, 2001
Last Update Posted:
May 17, 2017
Last Verified:
Jul 1, 2005
Additional relevant MeSH terms: